Hybrid and tandem expression of Neisserial proteins

Details for Australian Patent Application No. 2002339217 (hide)

International Classifications

Event Publications

27 February 2003 Complete Application Filed

Priority application(s): 0121591.2 06.09.01 GB

5 June 2003 Application Open to Public Inspection

Published as AU-B-2002339217

1 May 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

10 July 2008 Alteration of Name

The name of the applicant has been altered to Novartis Vaccines and Diagnostics S.r.l

17 July 2008 Section 223 Application Received

Novartis Vaccines and Diagnostics S.r.l An application to extend the time from 06 Sep 2007 to 06 May 2008 in which to pay a continuation fee has been filed . Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000 2003

4 September 2008 Section 223 Application Allowed

Novartis Vaccines and Diagnostics S.r.l The time in which to pay a continuation fee has been extended to 06 May 2008. Address for service in Australia - FB Rice & Co Level 23 200 Queen Street Melbourne VIC 3000 2003

4 September 2008 Application Accepted

Published as AU-B-2002339217

8 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.